Skip to main content

Table 1 Results LBC versus histology and HPV testing

From: A population-based observational study comparing Cervista and Hybrid Capture 2 methods: improved relative specificity of the Cervista assay by increasing its cut-off

   Primary Histology (N = 139)  
  Not performed Normal Borderline CIN1 CIN2 CIN3+ Total
LBC N(Cer+,HC2+) N(Cer+,HC2+) N(Cer+,HC2+) N(Cer+,HC2+) N(Cer+,HC2+) N(Cer+,HC2+) N(Cer+, HC2+)
Normal (Pap I/II) 1,208 (130, 69) 0 0 0 0 0 1,208 (130, 69)
ASC-US (Pap IIw) 65 (20, 18) 0 0 0 0 0 65 (20, 18)
ASC-H, AGUS (Pap III) 14 (6, 5) 0 1 (0, 0) 0 0 5 (4, 4) 20 (10, 9)
LSIL, HSIL (Pap IIID) 312 (197, 211) 21 (16, 18) 1 (1, 1) 5 (4, 4) 13 (12, 13) 20 (20, 20) 372 (250, 267)
HSIL, CIS (Pap IVa) 3 (3, 3) 1 (1, 1) 0 3 (3, 3) 6 (6, 6) 58 (56, 58) 71 (69, 71)
HSIL, CIS, Micro (IVb) 0 0 0 0 0 2 (2, 2) 2 (2,2)
Microinvasive (Pap V) 0 0 0 0 0 3 (3, 3) 3 (3, 3)
Total 1,602 (356, 306) 22 (17, 19) 2 (1, 1) 8 (7, 7) 19 (18, 19) 88 (85, 87) 1,741 (484, 439)
  1. Cer+: Cervista positive; HC2+: HC2 positive.